Header Logo

Connection

Naoko Takebe to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about TOR Serine-Threonine Kinases.
Naoko Takebe
Connection Strength
0.221
TOR Serine-Threonine Kinases
  1. Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D. JCO Precis Oncol. 2024 Sep; 8:e2400258.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.